CIBC Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.8M | Sell |
104,292
-2,601
| -2% | -$1.15M | 0.11% | 132 |
|
|
2026
Q1 | $47.7M | Sell |
106,893
-748
| -0.7% | -$349K | 0.12% | 135 |
|
|
2025
Q4 | $48.8M | Buy |
107,641
+26,636
| +33% | +$11.5M | 0.12% | 134 |
|
|
2025
Q3 | $31.7M | Buy |
81,005
+19
| +0% | +$7.94K | 0.09% | 147 |
|
|
2025
Q2 | $36.1M | Sell |
80,986
-4,393
| -5% | -$2.02M | 0.11% | 129 |
|
|
2025
Q1 | $41.4M | Buy |
85,379
+888
| +1% | +$414K | 0.14% | 114 |
|
|
2024
Q4 | $34M | Buy |
84,491
+4,389
| +5% | +$2.03M | 0.11% | 129 |
|
|
2024
Q3 | $37.3M | Buy |
80,102
+4,432
| +6% | +$2.13M | 0.12% | 120 |
|
|
2024
Q2 | $35.5M | Sell |
75,670
-674
| -0.9% | -$293K | 0.13% | 119 |
|
|
2024
Q1 | $31.9M | Buy |
76,344
+4,236
| +6% | +$1.79M | 0.11% | 129 |
|
|
2023
Q4 | $29.3M | Buy |
72,108
+7
| +0% | +$2.59K | 0.11% | 132 |
|
|
2023
Q3 | $25.1M | Buy |
72,101
+7,169
| +11% | +$2.51M | 0.1% | 137 |
|
|
2023
Q2 | $22.9M | Sell |
64,932
-376
| -0.6% | -$127K | 0.09% | 153 |
|
|
2023
Q1 | $20.6M | Buy |
65,308
+847
| +1% | +$254K | 0.08% | 158 |
|
|
2022
Q4 | $18.6M | Sell |
64,461
-1,577
| -2% | -$481K | 0.08% | 160 |
|
|
2022
Q3 | $19.1M | Buy |
66,038
+3,115
| +5% | +$896K | 0.08% | 151 |
|
|
2022
Q2 | $17.7M | Sell |
62,923
-4,664
| -7% | -$1.25M | 0.07% | 152 |
|
|
2022
Q1 | $17.6M | Sell |
67,587
-55
| -0.1% | -$13.1K | 0.06% | 171 |
|
|
2021
Q4 | $14.9M | Buy |
67,642
+6,305
| +10% | +$1.23M | 0.05% | 185 |
|
|
2021
Q3 | $11.1M | Buy |
61,337
+4,109
| +7% | +$802K | 0.04% | 213 |
|
|
2021
Q2 | $11.5M | Buy |
57,228
+2,690
| +5% | +$563K | 0.05% | 213 |
|
|
2021
Q1 | $11.7M | Buy |
54,538
+6,965
| +15% | +$1.53M | 0.05% | 200 |
|
|
2020
Q4 | $11.2M | Buy |
47,573
+3,021
| +7% | +$693K | 0.05% | 201 |
|
|
2020
Q3 | $12.1M | Buy |
44,552
+6,032
| +16% | +$1.66M | 0.06% | 172 |
|
|
2020
Q2 | $11.2M | Buy |
38,520
+1,144
| +3% | +$310K | 0.07% | 166 |
|
|
2020
Q1 | $8.89M | Buy |
37,376
+664
| +2% | +$152K | 0.06% | 170 |
|
|
2019
Q4 | $8.04M | Buy |
36,712
+1,421
| +4% | +$288K | 0.05% | 184 |
|
|
2019
Q3 | $5.98M | Sell |
35,291
-183
| -0.5% | -$32.4K | 0.04% | 219 |
|
|
2019
Q2 | $6.5M | Buy |
35,474
+987
| +3% | +$173K | 0.04% | 202 |
|
|
2019
Q1 | $6.34M | Sell |
34,487
-22
| -0.1% | -$4.06K | 0.04% | 202 |
|
|
2018
Q4 | $5.72M | Buy |
34,509
+601
| +2% | +$104K | 0.04% | 182 |
|
|
2018
Q3 | $6.54M | Buy |
33,908
+627
| +2% | +$112K | 0.04% | 182 |
|
|
2018
Q2 | $5.66M | Buy |
33,281
+1,986
| +6% | +$308K | 0.04% | 202 |
|
|
2018
Q1 | $5.1M | Sell |
31,295
-247
| -0.8% | -$40.3K | 0.03% | 213 |
|
|
2017
Q4 | $4.73M | Sell |
31,542
-310
| -1% | -$45.9K | 0.03% | 233 |
|
|
2017
Q3 | $4.84M | Buy |
31,852
+641
| +2% | +$96.5K | 0.03% | 223 |
|
|
2017
Q2 | $4.02M | Buy |
31,211
+977
| +3% | +$118K | 0.03% | 249 |
|
|
2017
Q1 | $3.31M | Buy |
30,234
+531
| +2% | +$46.7K | 0.02% | 283 |
|
|
2016
Q4 | $2.19M | Buy |
29,703
+415
| +1% | +$33.8K | 0.02% | 369 |
|
|
2016
Q3 | $2.55M | Sell |
29,288
-1,924
| -6% | -$182K | 0.02% | 330 |
|
|
2016
Q2 | $2.69M | Buy |
31,212
+511
| +2% | +$44.2K | 0.02% | 313 |
|
|
2016
Q1 | $2.44M | Buy |
30,701
+709
| +2% | +$64.1K | 0.02% | 328 |
|
|
2015
Q4 | $3.77M | Buy |
29,992
+13
| +0% | +$1.57K | 0.03% | 224 |
|
|
2015
Q3 | $3.12M | Buy |
29,979
+397
| +1% | +$51K | 0.03% | 258 |
|
|
2015
Q2 | $3.65M | Buy |
29,582
+1,341
| +5% | +$169K | 0.03% | 258 |
|
|
2015
Q1 | $3.33M | Buy |
28,241
+2,054
| +8% | +$246K | 0.02% | 271 |
|
|
2014
Q4 | $3.11M | Sell |
26,187
-6,798
| -21% | -$766K | 0.02% | 265 |
|
|
2014
Q3 | $3.71M | Sell |
32,985
-122
| -0.4% | -$11.6K | 0.02% | 258 |
|
|
2014
Q2 | $3.13M | Sell |
33,107
-1,022
| -3% | -$71.7K | 0.02% | 315 |
|
|
2014
Q1 | $2.41M | Buy |
34,129
+4,954
| +17% | +$392K | 0.01% | 369 |
|
|
2013
Q4 | $2.17M | Buy |
29,175
+709
| +2% | +$49.4K | 0.01% | 372 |
|
|
2013
Q3 | $2.16M | Buy |
28,466
+17,889
| +169% | +$1.42M | 0.01% | 352 |
|
|
2013
Q2 | $847K | Buy |
+10,577
| New | +$779K | 0.01% | 557 |
|
Other funds holding VRTX
CIBC Asset Management's VRTX Position: Q2 2026 in Review
CIBC Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q2 2026, selling an estimated $1.15M and leaving 104,292 shares worth $51.8M. The position accounts for 0.11% of the portfolio, ranked #132.
CIBC Asset Management first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- CIBC Asset Management held 104,292 shares of Vertex Pharmaceuticals worth $51.8M as of Q2 2026.
- CIBC Asset Management sold 2,601 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.15M.
- Vertex Pharmaceuticals made up 0.11% of CIBC Asset Management's portfolio in Q2 2026, its #132 holding.
- CIBC Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.